Issue Information – Table of Contents
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents
Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once‐daily intravenous busulfan dosing nomogram
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS‐R)
Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease : A triple‐blind, randomized trial
Renal outcomes in patients with AL amyloidosis : Prognostic factors, renal response and the impact of therapy
Monocytosis in polycythemia vera : Clinical and molecular correlates
Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation : An analysis from the acute leukemia working party of the EBMT
A phase 1 study of AMG 900, an orally administered pan‐aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes
The association of histologic grade with acute graft‐versus‐host disease response and outcomes
Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma
Acquired hemophilia A : Updated review of evidence and treatment guidance
The aggressive peripheral T‐cell lymphomas : 2017
Plasmodium knowlesi
Neonatal anemia : Revisiting the enigmatic pyknocyte
DAT‐positive Plasmodium ovale malaria presenting in a child with sickle cell anemia
NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification
A multicenter prospective study on efficacy and safety of imatinib generics : A report from Polish Adult Leukemia Group imatinib generics registry
The 2016 WHO diagnostic criteria for polycythemia vera renders an accurate diagnosis to a broader range of patients including masked polycythemia vera : Comparison with the 2008 WHO diagnostic criteria
Anemia is present years before myelodysplastic syndrome diagnosis : Results from the pre‐diagnostic period
Monosomal karyotype in chronic lymphocytic leukemia : Association with clinical and biological features and potential prognostic significance
Chronic lymphocytic leukemia and prognostic models : A bridge between clinical and biological markers